Exploratory Clinical Development World Europe 2012

March 26, 2012

Health Network Communications, Business Design Centere, London 2012-05-23 Day One: New approaches in de-risking candidate selection The yin and yang of biomarkers Stimulating open innovation and collaborations in pharma Design strategies for success in early phase trials Accelerating early development Biomarkers in early development Translational medicine First in human safety

Organized by:			Health Network Communications
Invited Speakers:			Balaji Agoram Director, Clinical Pharmacology MedImmune Khusru Asadullah Vice President, Head of Global Biomarkers Bayer Healthcare Jiri Aubrecht Senior Director and Group Lead of Safety Biomarker Laboratories Pfizer Laurent Audoly Head of R&D and Chief Scientific Officer Pieris Daren Austin Head, Biopharm Clinical Pharmacology & Biometrics GlaxoSmithKline Massimo Bani Global Head Clinical Pharmacology UCB Pharma SA Richard Buller Vice President, Translational Oncology Pfizer olf Burghaus Head Modeling & Simulation Bayer Pharma Gvido Cebers Senior Project Director; CNSP iMED Lead Toxicologist AstraZeneca R&D

Deadline for Abstracts:			2012/03/26

Registration:			Register online at: https://secure.terrapinn.com/V5/rCalc.aspx?E=4943 or cal Sabrina on +44 (0) 207 608 7055
E-mail:			jphillips@healthnetworkcommunications.com

events